Volume 10, Issue 4 (8-2012)                   IJRM 2012, 10(4): 349-354 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghaseminejad A, Rezaee Z, Forootan M, Hosseinipoor T, Forghani F, Nikuei P. Effect of predictive value of progesterone level on the day of HCG injection for IVF success in women with infertility due to tubal factor or polycystic ovarian syndrome referred to the women hospital, Tehran, 2009. IJRM. 2012; 10 (4) :349-354
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-289-en.html
1- Department of Obstetrics and Gynecology, Mirza Kouchakkhan Hospital, Tehran University of Medical Sciences, Tehran, Iran
2- Department of Obstetrics and Gynecology, Zabol University of Medical Sciences, Zabol, Iran
3- Hormozgan Fertility and Infertility Research Center, Hormozgan University of Medical Sciences, Bandarabbas, Iran , p_nik2000@yahoo.com
Abstract:   (1615 Views)
Background: Polycystic ovarian syndrome is one of the most common causes of endocrine disorders and main reason of infertility due to anovulation and recurrent abortions. Progesterone has been shown to have an important role in fertilization of oocyte and fetal implantation.
Objective: The purpose of this study was to compare the predictive value of progesterone level on IVF success in women with infertility due to tubal factor or PCOS.
Materials and Methods: In a stratified cohort study, we assigned 76 infertile women of 20-38 years old who referred to women hospital into two equal groups with fallopian tube factor infertility and PCOS. We measured the plasma levels of progesterone and estradiol on the day of HCG administration. The patients were divided into two groups based on progesterone level cut off point of 1.2ng/ml. Thereafter the incidence of pregnancy (chemical by β-HCG measurement and clinical by ultrasonography up to the 6 weeks after fetal transfer) was compared in these groups.
Results: Total pregnancy rates were 15.8% in patients with tubal factor infertility and 26.3% in women with PCOS. In women with PCOS, the pregnancy rate was less in patients with progesterone level <1.2 ng/ml. However this difference was not statistically significant. Likewise, we did not observe any significant differences in pregnancy rate in patients with fallopian tube factor infertility.
Conclusion: Serum progesterone level on the day of HCG administration is not well predictive of the IVF success in infertile women due to fallopian tube factor or PCOS. To obtain more uniform results, we recommend use of larger samples while the bias variable is taken into account and the ROC curve is used for determination of the unique serum progesterone level.
Full-Text [PDF 489 kb]   (246 Downloads) |   |   Full-Text (HTML)  (92 Views)  
Type of Study: Original Article |

References
1. Homburg R. Clomiphen citrate-end of an era? A mini review. Hum Reprod 2005; 20: 2043-2051. [DOI:10.1093/humrep/dei042]
2. Ghasemi N, Mortazavi MR, Khorasani A. Frequency of Poly cystic ovary syndrome in patients with premenopausal breast cancer. Iran J Reprod Med 2010; 8: 86-89.
3. Kamath MS, George K. Letrozole or clomiphen citrate as firsth line for anovulatory infertility. Reprod Biol Endocrinol 2011; 9: 86. [DOI:10.1186/1477-7827-9-86]
4. Doldi N, Marsiglio E, Destefani A, Gessi A, Merati G, Ferrari A. Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Hum Reprod 1999; 14: 601-605. [DOI:10.1093/humrep/14.3.601]
5. Edelstein MC, Seltman HJ, Cox BJ, Robinson SM, Shaw RA, Muasher SG. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropines-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril 1990; 54: 853-857. [DOI:10.1016/S0015-0282(16)53945-4]
6. Silverberg KM, Martin M, Olive DL, Burns WN, Schenken RS. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration in in-vitro fertilization cycles do not adversely affect embryo quality. Fertil Steril 1994; 61: 508-513. [DOI:10.1016/S0015-0282(16)56584-4]
7. Hoffman GE, Bentzien F, Bergh PA, Garrisi GJ, Williams MC, Guzman I, et al. Premature luteinization in controlled ovarian hyper stimulation has no adverse effect on oocyte and embryo quality. Fertil Steril 1993; 60: 675-679. [DOI:10.1016/S0015-0282(16)56221-9]
8. Hoffman GE, Khoury J, Johnson CA, Thie J, Scott RT Jr. Premature luteinization during controlled ovarian hyper stimulation for in-vitro fertilization- embryo transfer has no impact on pregnancy outcome. Fertil Steril 1996; 66: 980-986. [DOI:10.1016/S0015-0282(16)58693-2]
9. Legro RS, Ary BA, Paulson RJ, Stanczyk FZ, Sauer MV. Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization. Hum Reprod 1993; 8: 1506-1511. [DOI:10.1093/oxfordjournals.humrep.a138288]
10. Mio Y, Sekijima A, Iwabo T, Onohara Y, Harada T, Terakawa N. Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in-vitro fertilization. Fertil Steril 1992; 58: 159-166. [DOI:10.1016/S0015-0282(16)55154-1]
11. Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC. Is progesterone elevation on the day of human chorionic gonadotrophin administration assossaiated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update 2007; 13: 343-355. [DOI:10.1093/humupd/dmm007]
12. Elnashar AM. Progesterone rise on the day of HCG administration (premature Luteinization) in IVF: An overdue update. J Assist Reprod Genet 2010; 27: 149-155. [DOI:10.1007/s10815-010-9393-8]
13. Martinez F, Coroleu B, Clua E, Tur R, Buxaderas R, Parera N, et al. serum progesterone concentration on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles. Reprod Biomed Online 2004; 8: 183-190. [DOI:10.1016/S1472-6483(10)60514-7]
14. Huang JC, Jackson KV, Hornstein MD, Ginsburg ES. The effect of elevated serum progesterone during ovulation induction in in-vitro fertilization-embryo transfer. J Assist Reprod Genet 1996; 13: 617-624. [DOI:10.1007/BF02069639]
15. Abuzeid MI, Sasy MA. Elevated progesterone levels in the late follicular phase do not success of in-vitro fertilization- embryo transfer. Fertil Steril 1996; 65: 981-985. [DOI:10.1016/S0015-0282(16)58273-9]
16. Bustillo M, Stern JJ, Coulam CB. Serum progesterone at the time of human chorionic gonadotropin dose not predict pregnancy in in-vitro fertilization and embryo transfer. Hum Reprod 1995; 10: 2862-2867. [DOI:10.1093/oxfordjournals.humrep.a135808]
17. Schoolcraft W, Sinton E, Schlenker T, Huynh D, Hamilton F, Meldrum DR. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 1991; 55: 563-566. [DOI:10.1016/S0015-0282(16)54186-7]
18. Harada T, Yoshida S, Katagiri C, Takao N, Ikenari T, Toda T, et al. Reduced implantation rate associated with a subtle rise in serum progesterone concentration during the follicular phase of cycles stimulated with a combination of a gonadotropin- releasing hormone agonist and gonadotrophin. Hum Reprod 1995; 10: 1060-1064. [DOI:10.1093/oxfordjournals.humrep.a136094]
19. Burns WN, Witz CA, Klein NA, Silvarberg KM, Schenken RS. Serum progesterone concentrations on the day after human chorionic gonadotropin administration and progesterone/ oocyte rations predict in-vitro fertilization/ embryo transfer outcome. J Assist Reprod Genet 1994; 11: 17-23. [DOI:10.1007/BF02213692]
20. Dirnfeld M, Goldman S, Gonen Y, Koifman M, Lissak A, Abramovici H. A modest increase I serum progesterone levels on the day of human chorionic gonadotropin (hCG) administration may influence pregnancy rate and pregnancy loss in in-vitro fertilization-embryo transfer (IVF-ET) patients. J Assist Reprod Genet 1993; 10: 126-129. [DOI:10.1007/BF01207734]
21. Edelstein MC, Seltman HJ, Cox BJ, Robinson SM, Shaw RA, Muasher SJ. Progesterone level on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone against suppression is not predictive of pregnancy outcome. Fertil Steril 1990; 54: 853-857. [DOI:10.1016/S0015-0282(16)53945-4]

Send email to the article author


© 2021 CC BY-NC 4.0 | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb